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ABSTRACT : 
Miller Fisher Syndrome (MFS) is a rare variant of Guillain-Barré syndrome (GBS) which is an idiopathic 
neuromuscular paralysis. It is considered as autoimmune disease because there are antibodies which attack the 
nerve cell ﬁbers resulting in paralysis of muscles. This disease exhibits a classic clinical triad of ataxia,areﬂexia, and 
ophthalmoplegiawhereas it could have more neurological symptoms.Basically it is diagnosed clinically but have a 
serological test for its conﬁrmation i.e. anti-GQ1b antibody levels.Here, we report a stereotypical case of MFS with all 
of its cardinal symptoms with addition of some other symptoms like diplopia, ptosis of an eye and unilateral facial 
nerve palsy. This patient presented with all of these signs and symptoms preceded by an upper respiratory tract 
illness. The suspected diagnosis was aided with itsserological marker anti-GQ1b antibody levels and nerve 
conduction studies(NCS)/electromyographic(EMG)studies and the patient was successfully treated with multiple 
sessions of plasmapheresis and reduction in severity of the disease was noticed.
KEYWORDS: 
Miller Fisher Syndrome(MFS), Guillain-Barré syndrome(GBS),anti-GQ1b ganglioside antibodies(anti-GQ1b 
antibody), Upper respiratory tract illness(URTI),nerve conduction studies(NCS).
INTRODUCTION: 
In 1932, James Collier was the ﬁrst person to 
acknowledge this disease but later on it was 
named after Charles Miller Fisher(Canadian 
1
neurologist) who reported 3 cases in 1956 . This 
rare variant of GBS, is only noticed in about 1-5% 
2
of all cases of GBS in Western regions of world . 
MFS symptoms usually begins within 1-2 weeks 
after a respiratory infection similarly to GBS with 
rapid evolution of its cardinal triadi.e.ataxia, are 
ﬂexia, and ophthalmoplegia. The pivotal 
dissimilarity between MFS and other common 
variants of GBS is that the cranial nerves are 
affected ﬁrst resulting in weakness of muscles  
within or surrounding the eye with poor balance 
& . While, paralysis in other clumsy swaying walk
2-3
forms of GBS typically initiate in the legs . Here, 
we discuss a case of young woman with likely 
MFS mingling with some my as the niagraves' 
presentation symptoms.
CASE REPORT:
A 38 years old female, married and working as a 
teacher presented to us with complains of double 
vision, drooping of left eyelid & difﬁculty in walking 
for the last 2 weeks. 
These symptomswere progressive in nature & 
were accelerating each day. All this started after 
an upper respiratory tract illness which was 
almost 10-12 days prior to the onset of these 
presenting complains. The symptoms were 
vague at the beginning but with time they were 
b e c o m i n g  m o r e  p r o m i n e n t  i n  n a t u r e 
andparesthesias in both upper limbs alongwith an 
opthalmoplegia had developed in the next few 
days. She had no signiﬁcant past medical and 
surgical history. She did not complain of any 
bowel or urinary incontinence. Her personal 
history was normal with good appetite and did not 
have any smoking or alcohol intake history. In her 
family none was diagnosed and treated for any 
neurological diseases. She denied of taking any 
allopathic and herbal medicine except for 
herURTI (ﬂuoroquinolones) in the recent past.
On physical examination her vitals were in normal 
range and she was oriented in time place and 
person. Her facial examination revealed that 
there was ptosis in left eye, could not look up and 
was unable to show teeth especially, left side of 
face. Later on in the next 1-2 day, she also had
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MFS usually presents with its cardinal triad of 
signs/symptoms(opthalmoplegia, ataxia, areﬂexia). 
The less frequent complains associated with MFS are 
u r inary  d is tu rbances ,  fac ia l  and  pup i l la ry 
palsies,dysesthesias of l imbsand mild motor 
2
weaknesses . URTI is the most common preceded 
event in majority of the cases of GBS and MFS (56-
76%). Moreover, the frequently involvedpathogens for 
th is  a i lment  are Campylobacter  je juni  and 
8-9
Haemophilus inﬂuenzae .
 Mostly, opthalmoplegia is the ﬁrst presenting symptom 
in a patient and it can be easily differentiated from other 
chronic diseases like myasthenia gravis andmyotonic 
dystrophybecause of its early onset of symptoms. The 
body weakness in MFS shows a descending pattern 
when compared to GBS (ascending paralysis) and 
along with eye problems(opthalmoplegia,diplopia) 
2,5
which is also very uncommon in it . Areﬂexia, can be 
present in several other conditions like metabolic 
abnormalities(hypomagnesemia, use of medication 
like antidepressants), diabetes, vitamin b12 deﬁciency 
and lower motor neuron diseases. In our patient there 
was no history of any chronic disease, trauma or any 
use of drugs and all lab investigations were within 
normal limits except of mild leucocytosis and 
thrombocytosis.
Heavy metal work up was not needed ﬁrstly, as patient 
is a teacher so exposure to any heavy metals is very 
less l ikely(also gave no history)& secondly 
opthalmoplegia is not present in metal poisonings only 
peripheral neuropathies occurs mostly in it.  
Multiple sclerosis was the ﬁrst thing to be ruled out as 
MRI brain was absolutely normal (following the 
McDonald's criteria) thus omitting the need of lumbar 
puncture for oligoclonal bands in CSF. 
A diagnosis of MFS can be made with proper history, 
clinical examination, focusing on the triad of 
symptoms, with normal metabolic panel and 
inconclusive or normal studies of CT/MRI. EMG should 
be done to differentiate it from myasthenia gravis. The 
anti-GQ1b ganglioside antibodies level is the most 
sensitive serological test and it can be raised in 90% of 
the patients having MFS and completely negative in 
3
normal population . This antibody level is not speciﬁc 
for MFS  but it could be present  in “anti-GQ1b 
antibody syndrome” known for both central and 
peripheral nervous system deﬁcits.
Treatment for MFS is same as it is for GBS i.e. IVIG or 
plasmapheresis. Our patient had 5 sessions of 
plasmapheresis on alternate days after which her 
symptoms were resolved to almost 50% of the 
presenting ones(opthalmoplegia& gait much 
improved). 
Ataxia or wobbly gait and opthalmoplegia mostly 
resolve within 1-3 months of time period but complete 
2
recovery is forecasted within 6 months . Complications 
are rare but it could result in respiratory failure or 
6
cardiac arrhythmias or cardio pulmonary arrest .
deviation of angle of mouth (left sided).Eye 
examination revealed  paralysis of various ocular 
movements in both eyes and hadonly upward and 
medial gazes (suggestive of 3, 4, 6 nerve palsy). The 
pupils were round & small. Pupillary reﬂex was normal 
in right eye but was sluggish in left eye with a mildly 
dilated pupil. On oral examination sense of taste and 
bulk of tongue was good but she was having mild 
difﬁculty in swallowing various edibles. Furthermore, 
palatal palsy and nasal twang to voice was also 
observed.There was mild sensory loss in both hands, 
arms and all motor reﬂexes were absent in upper 
limbs. The reﬂexes were normal in lower limbs but heel 
shin test was mildly impaired. The plantar reﬂex was 
noted ﬂexor in both feet & showed no other focal 
sensory/motor deﬁcits.The gait was ataxic & waddling 
in nature.
H e r  l a b  i n v e s t i g a t i o n s  r e v e a l e d 
leucocytosis(67.2%neutrophils)& thrombocytosis in 
complete blood picture. The whole metabolic panel 
were innormal range(RFTs,LFTS,RBS).Moreover, 
electrocardiogram was normal and urinalysis showed 
no abnormalities.MRIbrainwas advised and results 
cameabsolutely  with mild cerebral unequivocal
atrophy and mild bilateral maxillary &ethmiodal 
sinusitisexculding completely the Multiple sclerosis. To 
exclude other neuromuscular diseases, such as 
muscular dystrophy, Myasthenia Gravis, nerve 
problems in the spine such as herniated disc & 
per ipheral  nerve problems in arms & legs 
electromyography (EMG)/NCS was done and it 
showed abnormal studies. In the present clinical 
scenario the EMG studies declared presence of small 
sensory amplitude in upper limb nerves (bilateral). To 
conﬁrm this suspected diagnosis anti-GQ1b antibody 
levels were sent and came backnegative. It will be 
present in most of the affected individuals but more 
7-8,10
than 10% patients will have seronegative results.
Then a central venous catheter was inserted infemoral 
vein of the patient. A total of 5 sessions of 
plasmapheresis were done on alternate days and her 
symptoms started improving after the second session. 
Physiotherapist was also involved and worked with 
patient on daily basis. She was discharged from 
th
hospital on 11 day of admission when she showed 
major positive development in her symptoms. The 
opthalmoplegia& gait was much improved as now she 
can move without support but still had a clumsy gait. 
She was asked for Outpatient follow-up after 2 weeks 
of discharge.
DISCUSSION:
Miller Fisher Syndrome(MFS) is a rare disease 
accounting more in male population than women by a 
3
ratio of approximately 2:1 . It is documented in wide 
range of ages but more commonly found in between 13 
2
& 78 years .  
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CONCLUSION:
Although, it is very uncommon disease but it carries a 
signiﬁcant place in the list of differential diagnosis of 
ataxia &opthalmoplegia. This disease should be kept 
in mind of a clinician because the vague presentation 
of it makes difﬁcult to diagnose or can be confused with 
other diseases.Thus,  theprognosis of MFS is very 
good irrespective of severity of symptoms and patients 
th
return to their normal life by 6  month of the onset of 
2
disease .
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